MedTrace Logo

Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

NCT01159925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2012-11-22

No results posted yet for this study

Summary

The purpose of this study is to collect epidemiological and clinical data to assess the vaccine impact and occurrence of confirmed acute hepatitis A cases in sentinel hospitals after the introduction of Havrix™ into the Expanded Program of Immunization.

Conditions

  • Acute Hepatitis A
  • Hepatitis

Interventions

PROCEDURE

Serum sample

Serum samples collected

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
1 Month
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Panama

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01159925 on ClinicalTrials.gov